Bausch Health Cos (BHC) Competitors $7.16 -0.11 (-1.44%) Closing price 03:59 PM EasternExtended Trading$7.30 +0.14 (+1.88%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BHC vs. ASND, RDY, QGEN, MRNA, BBIO, VRNA, ELAN, BPMC, ROIV, and GRFSShould you be buying Bausch Health Cos stock or one of its competitors? The main competitors of Bausch Health Cos include Ascendis Pharma A/S (ASND), Dr. Reddy's Laboratories (RDY), QIAGEN (QGEN), Moderna (MRNA), BridgeBio Pharma (BBIO), Verona Pharma PLC American Depositary Share (VRNA), Elanco Animal Health (ELAN), Blueprint Medicines (BPMC), Roivant Sciences (ROIV), and Grifols (GRFS). These companies are all part of the "pharmaceutical products" industry. Bausch Health Cos vs. Its Competitors Ascendis Pharma A/S Dr. Reddy's Laboratories QIAGEN Moderna BridgeBio Pharma Verona Pharma PLC American Depositary Share Elanco Animal Health Blueprint Medicines Roivant Sciences Grifols Bausch Health Cos (NYSE:BHC) and Ascendis Pharma A/S (NASDAQ:ASND) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations. Do institutionals & insiders believe in BHC or ASND? 78.7% of Bausch Health Cos shares are owned by institutional investors. 8.1% of Bausch Health Cos shares are owned by insiders. Comparatively, 40.0% of Ascendis Pharma A/S shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts recommend BHC or ASND? Bausch Health Cos presently has a consensus price target of $9.00, indicating a potential upside of 25.61%. Ascendis Pharma A/S has a consensus price target of $243.36, indicating a potential upside of 25.51%. Given Bausch Health Cos' higher probable upside, equities analysts plainly believe Bausch Health Cos is more favorable than Ascendis Pharma A/S.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Cos 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Ascendis Pharma A/S 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation and earnings, BHC or ASND? Bausch Health Cos has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than Bausch Health Cos, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch Health Cos$9.63B0.28-$46M$0.2627.56Ascendis Pharma A/S$393.54M30.16-$409.12M-$5.16-37.58 Does the media favor BHC or ASND? In the previous week, Bausch Health Cos had 1 more articles in the media than Ascendis Pharma A/S. MarketBeat recorded 15 mentions for Bausch Health Cos and 14 mentions for Ascendis Pharma A/S. Ascendis Pharma A/S's average media sentiment score of 1.41 beat Bausch Health Cos' score of 0.09 indicating that Ascendis Pharma A/S is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch Health Cos 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Ascendis Pharma A/S 11 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is BHC or ASND more profitable? Bausch Health Cos has a net margin of 0.99% compared to Ascendis Pharma A/S's net margin of -54.94%. Ascendis Pharma A/S's return on equity of 0.00% beat Bausch Health Cos' return on equity.Company Net Margins Return on Equity Return on Assets Bausch Health Cos0.99% -852.36% 5.25% Ascendis Pharma A/S -54.94%N/A -24.31% Which has more volatility and risk, BHC or ASND? Bausch Health Cos has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Ascendis Pharma A/S has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. SummaryBausch Health Cos beats Ascendis Pharma A/S on 9 of the 15 factors compared between the two stocks. Get Bausch Health Cos News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHC vs. The Competition Export to ExcelMetricBausch Health CosMED IndustryMedical SectorNYSE ExchangeMarket Cap$2.69B$4.18B$5.78B$21.32BDividend YieldN/A1.29%3.95%3.51%P/E Ratio27.5611.1031.2629.34Price / Sales0.2815.12464.6452.89Price / Cash0.947.1037.7323.86Price / Book17.914.8010.045.39Net Income-$46M-$109.62M$3.27B$996.59M7 Day Performance-4.40%-3.02%3.17%3.12%1 Month Performance4.14%16.91%4.34%2.97%1 Year Performance21.54%31.13%44.12%12.83% Bausch Health Cos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHCBausch Health Cos4.698 of 5 stars$7.17-1.4%$9.00+25.6%+22.1%$2.69B$9.63B27.5620,700Analyst RevisionASNDAscendis Pharma A/S3.43 of 5 stars$194.08-2.1%$242.93+25.2%+39.1%$12.14B$393.54M-37.611,017Positive NewsRDYDr. Reddy's Laboratories2.938 of 5 stars$14.26+0.2%$16.95+18.9%-13.7%$11.87B$3.81B21.6027,811News CoveragePositive NewsQGENQIAGEN4.0043 of 5 stars$48.66-1.4%$49.69+2.1%+7.3%$10.97B$1.98B21.035,765Positive NewsGap DownMRNAModerna4.4893 of 5 stars$28.09+0.2%$43.59+55.2%-68.2%$10.90B$3.24B0.005,800BBIOBridgeBio Pharma4.215 of 5 stars$49.02-4.5%$61.35+25.2%+98.5%$9.81B$221.90M0.00400VRNAVerona Pharma PLC American Depositary Share2.4855 of 5 stars$105.79+0.5%$109.00+3.0%+289.3%$8.96B$42.28M0.0030Positive NewsELANElanco Animal Health2.8586 of 5 stars$17.72-1.4%$17.33-2.2%+21.6%$8.92B$4.44B20.609,000Positive NewsBPMCBlueprint Medicines0.4177 of 5 stars$129.46flat$130.00+0.4%N/A$8.36B$562.12M-52.41640News CoverageROIVRoivant Sciences3.1773 of 5 stars$11.81-0.3%$16.50+39.7%+1.2%$8.06B$29.05M0.00860Positive NewsGRFSGrifols3.593 of 5 stars$10.58-1.3%$10.30-2.6%+11.9%$7.37B$7.45B9.0423,822Positive News Related Companies and Tools Related Companies Ascendis Pharma A/S Alternatives Dr. Reddy's Laboratories Alternatives QIAGEN Alternatives Moderna Alternatives BridgeBio Pharma Alternatives Verona Pharma PLC American Depositary Share Alternatives Elanco Animal Health Alternatives Blueprint Medicines Alternatives Roivant Sciences Alternatives Grifols Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHC) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Cos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Cos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access